NervGen Pharma's market value is the price at which a share of NervGen Pharma trades on a public exchange. It measures the collective expectations of NervGen Pharma Corp investors about its performance. NervGen Pharma is trading at 4.22 as of the 16th of February 2026. This is a 2.43% increase since the beginning of the trading day. The stock's lowest day price was 4.06. With this module, you can estimate the performance of a buy and hold strategy of NervGen Pharma Corp and determine expected loss or profit from investing in NervGen Pharma over a given investment horizon. Check out NervGen Pharma Correlation, NervGen Pharma Volatility and NervGen Pharma Performance module to complement your research on NervGen Pharma.
It's important to distinguish between NervGen Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NervGen Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NervGen Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
NervGen Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NervGen Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NervGen Pharma.
0.00
11/18/2025
No Change 0.00
0.0
In 3 months and 1 day
02/16/2026
0.00
If you would invest 0.00 in NervGen Pharma on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding NervGen Pharma Corp or generate 0.0% return on investment in NervGen Pharma over 90 days. NervGen Pharma is related to or competes with JW (Cayman), Brii Biosciences, Genfit SA, Scancell Holdings, Molecular Partners, NDT Pharmaceuticals, and Innate Pharma. NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of ph... More
NervGen Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NervGen Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NervGen Pharma Corp upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for NervGen Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NervGen Pharma's standard deviation. In reality, there are many statistical measures that can use NervGen Pharma historical prices to predict the future NervGen Pharma's volatility.
NervGen Pharma is risky given 3 months investment horizon. NervGen Pharma Corp has Sharpe Ratio of 0.2, which conveys that the firm had a 0.2 % return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.14% are justified by taking the suggested risk. Use NervGen Pharma Corp Downside Deviation of 4.45, mean deviation of 4.14, and Risk Adjusted Performance of 0.1499 to evaluate company specific risk that cannot be diversified away. NervGen Pharma holds a performance score of 15 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 2.61, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NervGen Pharma will likely underperform. Use NervGen Pharma Corp expected short fall, and the relationship between the value at risk and daily balance of power , to analyze future returns on NervGen Pharma Corp.
Auto-correlation
-0.79
Almost perfect reverse predictability
NervGen Pharma Corp has almost perfect reverse predictability. Overlapping area represents the amount of predictability between NervGen Pharma time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NervGen Pharma Corp price movement. The serial correlation of -0.79 indicates that around 79.0% of current NervGen Pharma price fluctuation can be explain by its past prices.
Other Information on Investing in NervGen OTC Stock
NervGen Pharma financial ratios help investors to determine whether NervGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NervGen with respect to the benefits of owning NervGen Pharma security.